Insider Trading: Aegerion Pharmaceuticals Inc (AEGR.W)
AEGR.W on CBOE When Trading NASDAQ Global Select Market
60.08USD
21 May 2013
60.08USD
21 May 2013
Price Change (% chg)
$-0.07 (-0.12%)
$-0.07 (-0.12%)
Prev Close
$60.15
$60.15
Open
$60.82
$60.82
Day's High
$60.90
$60.90
Day's Low
$60.08
$60.08
Volume
800
800
Avg. Vol
2,517
2,517
52-wk High
$62.81
$62.81
52-wk Low
$13.01
$13.01
| ADVENT PARTNERS HLS III L P | Options Exercised: 0 | ||
| Trade Date: | Sunday, 29 Jan 2012 | Price: | 17.06 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 28,217 |
| Type Traded: | Direct | Net Change in Shares This Filing: | -828 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 148 |
| Total Shares Held: | 30,770,021 |
| 3 Mo. Net Change: | 5,848,735 |
| # New Positions: | 44 |
| # Closed Positions: | 13 |
| # Increased Positions: | 109 |
| # Reduced Positions: | 45 |
| # Net Buyers: | 64 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Scheer |
60 | 2005 | Independent Chairman of the Board |
Marc Beer |
48 | 2010 | Chief Executive Officer, Director |
Mark Fitzpatrick |
49 | 2011 | Chief Financial Officer |
Anne Cook |
50 | 2011 | Senior Vice President, General Counsel, Secretary |
Martha Carter |
59 | 2011 | Chief Regulatory Officer and Senior Vice President |
Mark Sumeray |
46 | 2011 | Chief Medical Officer |
Anne VanLent |
2013 | Director | |
Sol Barer |
2011 | Independent Director | |
Antonio Gotto |
76 | 2006 | Independent Director |
Sandford Smith |
65 | 2012 | Independent Director |
Paul Thomas |
56 | 2011 | Independent Director |
Amanda Murphy |
IR Contact Officer |

